HSMN NewsFeed
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you the latest items in this publication.
6380 records returned
Pfizer Receives FDA Approval For Geodon(R) (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Data Show Geodon Used as an Adjunct to Lithium or Valproate Is Effective in the Maintenance Treatment of Bipolar I Disorder
NEW YORK--(HSMN NewsFeed)--Pfizer today announced that the U.S. Food and Drug Administration (FDA) has approved Geodon(R) (zipras... Biopharmaceuticals, FDAPfizer, Geodon, ziprasidone, bipolar disorder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 20, 2009 Category: Pharmaceuticals Source Type: news
Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal StentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Complete portfolio of Company's WallFlex Stent family of self-expanding metal stents now available in U.S., Europe and other international markets
NATICK, Mass. and LONDON, Nov. 20 (HSMN NewsFeed) -- Boston Scientific Corporation (NYSE: BSX ) today an... Devices, Interventional, Gastroenterology, FDABoston Scientific, WallFlex, Esophageal Stent, esophageal stricture (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 20, 2009 Category: Pharmaceuticals Source Type: news
FDA Approves Intravenous Formulation Of Pfizer's Revatio(R) (Sildenafil) For The Treatment Of Pulmonary Arterial HypertensionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Revatio is the Only Treatment in Its Class with Both Oral and Intravenous Formulations
NEW YORK--(HSMN NewsFeed)--Pfizer announced today that the U.S. Food and Drug Administration (FDA) has approved Revatio(R) (sildenafil) Injection, an intravenous form... Biopharmaceuticals, FDAPfizer, Revatio, sildenafil, phosphodiesterase, pulmonary arterial hypertension (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 20, 2009 Category: Pharmaceuticals Source Type: news
FDA Extends Review of NDA for ExalgoEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ST. LOUIS--(HSMN NewsFeed)--Covidien (NYSE:COV ), a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) has set a new action date under the Prescription Drug User Fee Act for the review of the Ne... Biopharmaceuticals, FDACovidien, Exalgo, hydromorphone (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 20, 2009 Category: Pharmaceuticals Source Type: news
Smith and Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield InjuriesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
"Fracture putty" system to improve standard of care for injured soldiers
MEMPHIS, Tenn., Nov. 20 (HSMN NewsFeed) -- Smith & Nephew (NYSE: SNN, LSE: SN) Orthopaedics Division is pleased to announce the signing of a technology development cont... Devices, OrthopaedicSmith & Nephew, fracture putty (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 20, 2009 Category: Pharmaceuticals Source Type: news
Medtronic Chairman and CEO Bill Hawkins Provides Statement on U.S. Senate's Revised Medical Device Industry Fee ProposalEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Company Applauds Leadership of Sens. Dianne Feinstein and Barbara Boxer, Governor Arnold Schwarzenegger, Representative Anna Eshoo and the California Congressional Delegation
MINNEAPOLIS--(HSMN NewsFeed)--Medtronic, Inc. (NYSE: MDT ), chairman and CEO B... DevicesMedtronic (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 20, 2009 Category: Pharmaceuticals Source Type: news
Medtronic Chairman and CEO Bill Hawkins Comments on U.S. Senate's Revised Medical Device Industry Fee ProposalEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Company Applauds Leadership of Senators Amy Klobuchar and Al Franken, Governor Tim Pawlenty and the Minnesota Congressional Delegation
MINNEAPOLIS--(HSMN NewsFeed)--Medtronic, Inc. (NYSE: MDT ), chairman and CEO Bill Hawkins today issued the following s... DevicesMedtronic (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 20, 2009 Category: Pharmaceuticals Source Type: news
Statement by Medtronic Chairman and CEO Bill Hawkins Regarding U.S. Senate's Revised Medical Device Industry Fee ProposalEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Company Applauds Leadership of Senator Evan Bayh and the Indiana Delegation
MINNEAPOLIS--(HSMN NewsFeed)--Medtronic, Inc. (NYSE: MDT ), chairman and CEO Bill Hawkins today issued the following statement regarding the U.S. Senates revised proposal regar... DevicesMedtronic (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 20, 2009 Category: Pharmaceuticals Source Type: news
Anika Therapeutics Receives European CE Mark Approval for "ELEVESS Light"Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Company Expands Aesthetic Franchise with New Product Used to Treat Fine Lines and Wrinkles
Plans European Launch in Early 2010
BEDFORD, Mass.--(HSMN NewsFeed)--Anika Therapeutics, Inc. (Nasdaq: ANIK ), a leader in products for tissue protection, heal... Biopharmaceuticals, Dermatology, RegulatoryAnika Therapeutics, hyaluronic acid, ELEVESS, ELEVESS Light (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 19, 2009 Category: Pharmaceuticals Source Type: news
Smith and Nephew Supports New CPT Code for Multi-Layer Compression Bandaging SystemsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ST. PETERSBURG, Fla., Nov. 19 (HSMN NewsFeed) -- The Advanced Wound Management division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc (LSE: SN ; NYSE: SNN ), supports the American Medical Association's creation of the new Category (1) Curre... Devices, Wound Care, ReimbursementSmith & Nephew, VARI-STRETCH, PROGUIDE, PROFORE, compression bandaging (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 19, 2009 Category: Pharmaceuticals Source Type: news
Medtronic Introduces '3D Recon' Service to Enhance Endovascular Treatment of Aortic AneurysmsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Global Partnership with Vital Images Leverages Advanced Visualization Technology to Streamline Pre-Case Planning through Patient Follow-Up
MINNEAPOLIS--(HSMN NewsFeed)--Continuing to drive innovation in endovascular aortic repair (EVAR), Medtronic, Inc.... Devices, InterventionalMedtronic, endovascular aortic repair, 3D Recon, Vital Images Inc (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 19, 2009 Category: Pharmaceuticals Source Type: news
Delcath Systems Reports Substantial ProgressEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Recent Follow-On Public Offering Provides Resources to Execute Plan
Active Negotiations with Potential International Partners Continuing
Phase III Study Enrollment Completed
Executive Management Team Completed
NEW YORK, Nov. 19 (HSMN NewsFeed) -- D... Devices, OncologyDelcath Systems, Percutaneous Hepatic Perfusion, PHP System (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 19, 2009 Category: Pharmaceuticals Source Type: news
AstraZeneca Submits US New Drug Application for Ticagrelor (BRILINTA(TM)), an Investigational Antiplatelet AgentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
WILMINGTON, Del., Nov. 19 (HSMN NewsFeed) -- AstraZeneca (NYSE: AZN ) today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ticagrelor, an investigational oral antiplatelet treatment for the redu... Biopharmaceuticals, CardiologyAstraZeneca, ticagrelor, BRILINTA, acute coronary syndrome, PLATO (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 19, 2009 Category: Pharmaceuticals Source Type: news
Solta Medical Announces New Fraxel re:store(R) Dual Laser System, Receives CE Mark for European MarketEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
HAYWARD, Calif., Nov. 18 (HSMN NewsFeed) -- Solta Medical, Inc. (Nasdaq: SLTM ), the pioneer in fractional resurfacing and market leader of aesthetic skin treatments, today announced its European launch of the Fraxel re:store Dual laser system with the r... Devices, DermatologySolta Medical, Fraxel, re:store Dual laser (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 19, 2009 Category: Pharmaceuticals Source Type: news
Wright Medical Group, Inc. Announces Initial Release of the VALOR Ankle Fusion Nail SystemEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
New Foot & Ankle Product Solidifies Wrights Market-Leadership in Products for Surgical Treatment of Hindfoot Arthritis
ARLINGTON, Tenn.--(HSMN NewsFeed)--Wright Medical Group, Inc. (NASDAQ: WMGI ), a global orthopaedic medical device company, today ann... Devices, OrthopaedicWright Medical Group, VALOR Ankle Fusion Nail, (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 18, 2009 Category: Pharmaceuticals Source Type: news
New Updates to AHA/ACC/SCAI Clinical Guidelines Recommend Treatment with Effient(R) for Patients with Acute Coronary Syndromes Managed with PCIEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PARSIPPANY, N.J. and INDIANAPOLIS, Nov. 18 (HSMN NewsFeed) -- Effient® (prasugrel) tablets, a new antiplatelet medicine, was added as a treatment option in two clinical guideline updates: one for patients receiving percutaneous coronary intervention ... Biopharmaceuticals, CardiologyEli Lilly, Effient, prasugrel, antiplatelet, STEMI (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 18, 2009 Category: Pharmaceuticals Source Type: news
Sebelius Statement on New Breast Cancer RecommendationsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
WASHINGTON--(HSMN NewsFeed)--HHS Secretary Kathleen Sebelius issued the following statement today on new breast cancer screening recommendations from the U.S. Preventive Services Task Force:
There is no question that the U.S. Preventive Services Task F... Devices, Oncology, Radiologymammogram, mammography, breast cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 18, 2009 Category: Pharmaceuticals Source Type: news
Applied Spine Technologies' Stabilimax(R) Dynamic Spine System selected as "Best New Technology for 2009"Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Panel of 30 Independent Surgeon Judges Recognize Stabilimax in the Motion Preservation Category at the 2009 Spine Technology Awards
ROCKY HILL, Conn.--(HSMN NewsFeed)--Applied Spine Technologies, Inc. (www.appliedspine.com), a medical device company foc... Devices, Orthopaedic, NeurosurgeryApplied Spine Technologies, Stabilimax, motion preservation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 18, 2009 Category: Pharmaceuticals Source Type: news
BSD Medical Corporation Reports Continuation of FDA Review of BSD-2000 Hyperthermia SystemEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SALT LAKE CITY--(HSMN NewsFeed)--BSD Medical Corporation (NASDAQ: BSDM ) (www.bsdmedical.com) today provided an update on the U.S. Food and Drug Administrations (FDA) review of the Company's Humanitarian Device Exemption (HDE) marketing submission for the... Devices, Oncology, FDABSD Medical, BSD-2000, Hyperthermia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 18, 2009 Category: Pharmaceuticals Source Type: news
Radiation Breakthrough Gives Breast Cancer Patients Hope in Single DoseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Cancer Treatment Centers of America will be First in Country to Offer New Technology from Italy
PHILADELPHIA, Nov. 18 (HSMN NewsFeed) -- A radiation breakthrough to treat breast cancer patients in one day, as opposed to the current average of six week... Devices, OncologyHitesys, Novac7, Intraoperative Radiotherapy, IORT, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 18, 2009 Category: Pharmaceuticals Source Type: news
EKOS Corporation Launches the New EkoSonic(TM) MACH4e at VEITHsymposium in New YorkEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
No Limits to Treating Thrombus
NEW YORK--(HSMN NewsFeed)--Today EKOS Corporation launched the EkoSonic(TM) MACH4e with Rapid Pulse Modulation (RPM) for the dissolution of vascular blood clots at the 36th Annual VEITHsymposium in New York.
Robert W. H... Devices, InterventionalEKOS Corp, EkoSonic, MACH4e, thrombolysis, VEITHsymposium (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 18, 2009 Category: Pharmaceuticals Source Type: news
StemCells, Inc. Provides Update on NCL Program Meeting with FDAEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PALO ALTO, Calif.--(HSMN NewsFeed)--StemCells, Inc. (NASDAQ: STEM ) today provided an update on the ongoing clinical development program of its proprietary HuCNS-SC(R) product candidate (purified human neural stem cells) for neuronal ceroid lipofuscinosis ... Regenerative Medicine, Neurology, FDAStemCells, HuCNS-SC, neuronal ceroid lipofuscinosis, stem cell (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 18, 2009 Category: Pharmaceuticals Source Type: news
Depomed Promotes William Callahan to Vice President of OperationsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
MENLO PARK, Calif.--(HSMN NewsFeed)--Depomed, Inc. (NASDAQ:DEPO ) announced today that William Callahan has been promoted to vice president, Operations. Mr. Callahan joined Depomed in 2002 and most recently held the position of senior director, Operations.... Biopharmaceuticals, PersonnelDepomed (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 18, 2009 Category: Pharmaceuticals Source Type: news
Medtronic Receives FDA Warning Letter Following Inspection of Its Mounds View, Minn. FacilityEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
FDA Noted that the Companys Promised Corrective Actions Appear to be Adequate to Resolve the Issues Raised in the Letter
MINNEAPOLIS--(HSMN NewsFeed)--Medtronic (NYSE: MDT ) today announced it received a warning letter from the U.S. Food and Drug Admin... Devices, FDAMedtronic (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 18, 2009 Category: Pharmaceuticals Source Type: news
Gore Announces Availability of the Q50 Stent Graft Balloon CatheterEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Balloon Catheter from QXMédical complements GORE EXCLUDER® AAA Endoprosthesis for endovascular aortic repair
FLAGSTAFF, Ariz., Nov 18--(HSMN NewsFeed)--W. L. Gore & Associates (Gore) today announced it has entered into a partnership with QXM&... Devices, InterventionalW. L. Gore, QXMédical, Q50, Stent Graft Balloon Catheter, AAA, (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 18, 2009 Category: Pharmaceuticals Source Type: news
62-Year-Old Man Becomes First Patient in China Implanted with Rechargeable Neurostimulator for Chronic PainEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
St. Jude Medical receives Chinese State Food and Drug Administration approval for Eon and Genesis neurostimulators for chronic pain
ST. PAUL, Minn., Nov 18--(HSMN NewsFeed)--St. Jude Medical, Inc. (NYSE:STJ ) announced today that a 62-year-old man from ... DevicesSt. Jude Medical, Eon neurostimulator, rechargeable neurostimulator (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 18, 2009 Category: Pharmaceuticals Source Type: news
IsoRay Announces Distribution Agreement in CanadaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
RICHLAND, Wash.--(HSMN NewsFeed)--IsoRay, Inc. (Amex: ISR ) announced today that it has signed a distribution agreement with Inter V Medical of Montreal, Quebec, Canada. Inter V Medical will have exclusive rights to sell Cesium-131 Brachytherapy seeds in C... Devices, Oncology, DistributionIsoRay, Inter V Medical, Cesium-131, brachytherapy seeds (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 18, 2009 Category: Pharmaceuticals Source Type: news
Asuragen Signs Development and Worldwide Distribution Agreement with Life TechnologiesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Life Technologies to distribute Asuragens BCR/ABL1 leukemia assay for use on Applied Biosystems real-time PCR instrument
AUSTIN, Texas, Nov 18--(HSMN NewsFeed)--Asuragen, Inc. announced today that it has entered into an exclusive agreement with Life Te... Diagnostics, Oncology, DistributionAsuragen, Life Technologies Corp, BCR/ ABL1 assay, chronic myeloid leukemia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 18, 2009 Category: Pharmaceuticals Source Type: news
Basilea's Toctino(R) receives marketing authorization in CanadaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
BASEL, SWITZERLAND, Nov 18 -- (HSMN NewsFeed) - Basilea Pharmaceutica Ltd. announces that Toctino (alitretinoin), a new once-daily oral treatment for adults with severe chronic hand eczema (CHE) unresponsive to potent topical corticosteroids, has obtained ... Biopharmaceuticals, RegulatoryBasilea Pharmaceutica, Toctino, alitretinoin, chronic hand eczema (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 18, 2009 Category: Pharmaceuticals Source Type: news
New Genomic Test for Coronary Artery Disease Now Available at The Heart and Vascular Center of ArizonaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PHOENIX, Nov. 17 (HSMN NewsFeed) -- The Heart & Vascular Center of Arizona today announced the availability of Corus(TM) CAD, the first and only gene expression test to quantify the likelihood of obstructive(i) coronary artery disease (CAD) in patients w... Diagnostics, CardiologyCardioDx, Corus CAD, Coronary Artery Disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 17, 2009 Category: Pharmaceuticals Source Type: news
Thomas Memorial Hospital Completes Contract with Spacelabs Healthcare for Multi-Department Patient Monitoring SolutionsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ISSAQUAH, Wash. & CHARLESTON, W. Va.--(HSMN NewsFeed)--Thomas Memorial Hospital has completed the purchase to equip its critical care, perioperative, telemetry and outpatient surgery areas with the latest technology from Spacelabs Healthcare, a leader in p... Devices, MonitoringSpacelabs Healthcare, patient monitor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 17, 2009 Category: Pharmaceuticals Source Type: news
bioMerieux and GSK Sign Theranostics Agreement to Develop Predictive Test for Selecting Breast Cancer TreatmentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
MARCY L'ETOILE, France, Nov. 17 (HSMN NewsFeed) -- bioMerieux has signed an agreement with GlaxoSmithKline to develop a predictive test to help clinicians select the most appropriate treatment for different segments of breast cancer patients. This test, ... Biopharmaceuticals, Diagnostics, OncologybioMerieux, GlaxoSmithKline, Theranostics, personalized medicine, breast cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 17, 2009 Category: Pharmaceuticals Source Type: news
Pioneer(R) Surgical Technology, Inc. and Bonovo(R) Orthopedics, Inc. Establish Foothold in Fastest Growing Spine Market in the WorldEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Companies launch major product introduction for the 2009 Chinese Orthopaedic Association meeting in Xiamen.
MARQUETTE, Mich., Nov. 17 (HSMN NewsFeed) -- Bonovo Orthopedics, Inc., a leading Chinese manufacturer and distributor of orthopedic products, h... Devices, Orthopaedic, Neurosurgery, Regulatory, DistributionPioneer Surgical Technology, Bonovo Orthopedics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 17, 2009 Category: Pharmaceuticals Source Type: news
IDEV Technologies Names Christopher M. Owens President, Chief Executive OfficerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
William W. Burke Appointed Executive Vice President, Chief Financial Officer
HOUSTON, Nov. 17 (HSMN NewsFeed) -- IDEV Technologies, Incorporated (IDEV), an emerging leader in the development and marketing of minimally invasive medical technologies, to... Devices, Interventional, PersonnelIDEV Technologies (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 17, 2009 Category: Pharmaceuticals Source Type: news
Ellipse Technologies, Inc. Receives CE Mark Clearance for the MAGEC(TM) System for the treatment of Spinal ScoliosisEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
MAGEC System Provides Non-Invasive Remote Control Spine Therapy
IRVINE, Calif.--(HSMN NewsFeed)--Ellipse Technologies, Inc. (Ellipse) announced today it has received CE Mark (Conformité Européenne) for its MAGEC(TM) Technology for the tr... Devices, Orthopaedic, Neurosurgery, RegulatoryEllipse Technologies, MAGnetic Expansion Control, scoliosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 17, 2009 Category: Pharmaceuticals Source Type: news
Duke University Initiates Study of AEOL 10150 to Measure Compound's Ability to Protect Healthy Tissue in Mice Receiving Chemotherapy and Radiation for Non-Small Cell Lung CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
MISSION VIEJO, Calif.--(HSMN NewsFeed)--Aeolus Pharmaceuticals, Inc. (OTC Bulletin Board: AOLS ) announced today the initiation of a study to test the anti-tumor effects of AEOL 10150 when combined with radiation and chemotherapy in nude mice bearing human... Biopharmaceuticals, OncologyAeolus Pharmaceuticals, AEOL 10150, radiotherapy, non-small cell lung cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 17, 2009 Category: Pharmaceuticals Source Type: news
Abbott to Develop New Heart Failure Test on ARCHITECT(R) Immunochemistry Diagnostics PlatformEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ABBOTT PARK, Ill. and WALTHAM, Mass., Nov. 17 (HSMN NewsFeed) -- Abbott (NYSE: ABT ) and BG Medicine, Inc. today announced a development and commercialization agreement for galectin-3, a novel biomarker that may play a role in detecting the development a... Diagnostics, CardiologyAbbott, BG Medicine, immunochemistry, galectin-3, heart failure (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 17, 2009 Category: Pharmaceuticals Source Type: news
XOMA Appoints Jim Neal Vice President of Business DevelopmentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
BERKELEY, Calif., Nov. 17--(HSMN NewsFeed) -- XOMA Ltd. (Nasdaq:XOMA ), a leader in the discovery and development of therapeutic antibodies, today announced that James R. Neal has joined the company as Vice President, Business Development. Mr. Neal will ov... Biopharmaceuticals, PersonnelXOMA (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 17, 2009 Category: Pharmaceuticals Source Type: news
CONMED Linvatec Announces Launch of Novel Biocomposite Technology and Related Matryx(TM) Biocomposite Interference ScrewsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
UTICA, NY, Nov 17--(HSMN NewsFeed) - CONMED Corporation's (NASDAQ:CNMD ) CONMED Linvatec arthroscopy unit today announced the release of new sizes of its Matryx(TM) Biocomposite Interference Screw. These new screws represent the latest advance in biocompos... Devices, OrthopaedicCONMED, CONMED Linvatec, Matryx, Interference Screw (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 17, 2009 Category: Pharmaceuticals Source Type: news
Entellus Medical(R) Secures $30 Million Financing To Expand Commercialization of Novel Treatments for SinusitisEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
New treatment offers less invasive approach in $1 billion world-wide chronic sinusitis market
MINNEAPOLIS, Nov 17--(HSMN NewsFeed)--Entellus Medical, the Minnesota-based developer of novel, less invasive treatments for chronic conditions of sinusitis, h... Devices, Venture CapitalEntellus Medical (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 17, 2009 Category: Pharmaceuticals Source Type: news
Entellus Medical® Secures $30 Million Financing To Expand Commercialization of Novel Treatments for SinusitisEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
New treatment offers less invasive approach in $1 billion world-wide chronic sinusitis market
MINNEAPOLIS, Nov 17--(HSMN NewsFeed)--Entellus Medical, the Minnesota-based developer of novel, less invasive treatments for chronic conditions of sinusitis, h... Devices, Venture CapitalEntellus Medical (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 17, 2009 Category: Pharmaceuticals Source Type: news
Smith and Nephew Endoscopy Announces Availability of TRUCLEAR(TM) Hysteroscopic Morcellator at the AAGL Annual MeetingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Innovative System Allows for Efficient Removal of Intrauterine Polyps and Fibroids
ANDOVER, Mass., Nov. 17 (HSMN NewsFeed) -- Smith & Nephew's (NYSE: SNN ; LSE: SN ) Endoscopy Division announced the launch of the TRUCLEAR(TM) System, an operative hyst... DevicesSmith & Nephew, TRUCLEAR System, operative hysteroscopy, morcellator (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 17, 2009 Category: Pharmaceuticals Source Type: news
Genentech Submits Supplemental Applications to FDA for Avastin Combined with Commonly Used Chemotherapies for Women with Advanced Breast CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SOUTH SAN FRANCISCO, Calif.--(HSMN NewsFeed)--Genentech, Inc., a wholly-owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the company submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Dr... Biopharmaceuticals, OncologyGenentech, Roche Group, Avastin, bevacizumab, breast cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 17, 2009 Category: Pharmaceuticals Source Type: news
OSI Pharmaceuticals Announces Tarceva to Be Reviewed by the FDA's Oncologic Drugs Advisory Committee for Use as a First-Line Maintenance Therapy in Advanced Non-Small Cell Lung CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
MELVILLE, N.Y.--(HSMN NewsFeed)--OSI Pharmaceuticals, Inc. (NASDAQ: OSIP ) announced today that the Oncologic Drugs Advisory Committee (ODAC) will review the use of Tarceva(R) (erlotinib) as a first-line maintenance therapy for patients with advanced non-s... Biopharmaceuticals, Oncology, FDAOSI Pharmaceuticals, Tarceva, erlotinib, Non-Small Cell Lung Cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 16, 2009 Category: Pharmaceuticals Source Type: news
nContact Announces Initiation of Clinical Trials for the Treatment of Atrial Fibrillation in Open-Chest ProceduresEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
MORRISVILLE, N.C., Nov. 16 (HSMN NewsFeed) -- nContact Surgical, Inc. ("nContact"), a leader in the investigation of devices for non-invasive treatment for heart conditions, today announced the initiation of a clinical trial designed to evaluat... Devices, CardiologynContact Surgical, Numeris, Tethered Coagulation, atrial fibrillation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 16, 2009 Category: Pharmaceuticals Source Type: news
Synergetics USA, Inc. Announces Addendum to Marketing Partner Agreement with Codman and Shurtleff, Inc. for Disposable Bipolar ForcepsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
OFALLON, Mo.--(HSMN NewsFeed)--Synergetics USA, Inc. (NASDAQ: SURG ), a medical device company that designs, manufactures, and markets innovative microsurgical instruments and other devices, today announced the signing of an addendum to its three year agr... Devices, Neurosurgery, DistributionSynergetics, Codman & Shurtleff, Spetzler-Malis, bipolar forceps (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 16, 2009 Category: Pharmaceuticals Source Type: news
Cannasat Therapeutics Announces New Chief Executive Officer: Anthony J. Giovinazzo, M.B.A., C.Dir.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
TORONTO, ONTARIO - (HSMN NewsFeed) - Cannasat Therapeutics Inc. ("Cannasat") (TSX-V:CTH ) announced today that Anthony J. Giovinazzo has been appointed to succeed David Hill as Chief Executive Officer, and joins the Company as President and Chief... Biopharmaceuticals, PersonnelCannasat Therapeutics, Relivar (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 16, 2009 Category: Pharmaceuticals Source Type: news
Fate Therapeutics Closes $30 Million Series B FinancingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Led by OVP Venture Partners and Includes Syndicate of Corporate Investors
LA JOLLA, Calif., Nov. 16 (HSMN NewsFeed) -- Fate Therapeutics, Inc. announced today that it has completed a $30 million Series B financing led by OVP Venture Partners. Joining ... Regenerative Medicine, Biopharmaceuticals, Venture CapitalFate Therapeutics, pluripotent stem cell, Stem Cell Modulator (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 16, 2009 Category: Pharmaceuticals Source Type: news
Watson Names Robert A. Stewart Senior Vice President, Global OperationsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Restructures to Create Global Operations, Global Generics Commercial Functions
MORRISTOWN, N.J., Nov. 16 (HSMN NewsFeed) -- Watson Pharmaceuticals (NYSE: WPI ) today announced that Robert A. Stewart has joined the Company in the newly created position... Biopharmaceuticals, PersonnelWatson Pharmaceuticals (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 16, 2009 Category: Pharmaceuticals Source Type: news
CONMED Linvatec Announces Launch of Bullseye(TM) Anatomic Cruciate Reconstruction SystemEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
UTICA, NY, Nov. 16--(HSMN NewsFeed) - CONMED Corporation's (NASDAQ:CNMD ) CONMED Linvatec arthroscopy unit today announced the release of the Bullseye(TM) Anatomic Cruciate Reconstruction System, a novel guide system for anatomic cruciate ligament (ACL and... Devices, OrthopaedicCONMED, Bullseye System, cruciate ligament reconstruction (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 16, 2009 Category: Pharmaceuticals Source Type: news
